Defunct Company
Total Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
1,181
NCT01179646
Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets
Phase: Phase 1
Role: Lead Sponsor
Start: Jun 30, 2004
Completion: Aug 31, 2004
NCT01039233
Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions
Start: May 31, 2005
Completion: Jul 31, 2005
NCT01044706
Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex® 50 mg Tablet in Healthy Subjects Under Fed Conditions
NCT01179659
Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed Conditions
Start: Sep 30, 2005
Completion: Mar 31, 2006
NCT03486990
Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease
Role: Collaborator
Start: Jan 23, 2018
Completion: Jul 22, 2019
NCT03738475
Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease
Phase: Phase 2
Start: Nov 11, 2018
NCT05014490
Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers
Start: Feb 24, 2021
Completion: Mar 24, 2021
NCT05464745
Bioequivalence Study of 8 mg Perindopril Tert-butylamine / 2.5 mg Indapamide Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide Film-coated Tablets in Healthy Volunteers
Start: May 19, 2021
Completion: Jun 9, 2021
NCT05470764
Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers
Start: May 30, 2021
Completion: Jun 28, 2021
NCT04950504
Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Start: Jun 2, 2021
Completion: Jul 29, 2022
NCT05607641
Efficacy and Safety Study of Ketorolac / Pitofenone / Fenpiverinium for the Treatment of Patients With Pain After Surgical Abdominal and Pelvic Operations
Phase: Phase 2/3
Start: Jul 7, 2021
Completion: May 13, 2022
NCT05663372
Bioequivalence Study of Test and Reference 50 mg Eplerenone Film-coated Tablets in Healthy Volunteers
Start: Dec 7, 2021
Completion: Dec 28, 2021
NCT05104853
Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects with Primary Biliary Cholangitis
Phase: Phase 1/2
Start: Jan 25, 2022
Completion: Jan 30, 2026
NCT05250856
CNP-201 in Subjects With Peanut Allergy
Start: Mar 14, 2022
Completion: Dec 12, 2023
NCT05663398
Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers
Start: May 17, 2022
Completion: May 31, 2022
NCT06106672
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Start: May 30, 2024
Completion: Aug 31, 2026
NCT06783309
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Start: May 12, 2025
Completion: Jun 30, 2027